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Abstract
Background: The aim of the present study was to compare the efficacy of low doses of methylprednisolone, aceta-
minophen and dexketoprofen trometamol, which are among the drug groups used in our clinic, on postoperative 
swelling developing after removal of impacted third molar.
Material and Methods: The three group of patients received either 40 mg methylprednisolone or 300 mg aceta-
minophen or 12.5 mg dexketoprofen trometamol one hour before the procedure, according to the patient groups. 
The patients in the methylprednisolone group were injected with methylprednisolone at a dose of 20 mg 24 hour 
after the procedure and prescribed 300 mg acetaminophen as rescue analgesic. During the postoperative period, 
the doses that were given before the procedure were continued 3 times a day for 2 days in the acetaminophen and 
dexketoprofen trometamol groups. Maximal swelling was assessed preoperatively and at the postoperative 48 
hours by ultrasound images.
Results: Swelling was 34% lower in the methylprednisolone than in the other groups; however, no statistically 
significant difference was found between the groups. The acetaminophen and dexketoprofen trometamol groups 
exhibited clinical results close to each other.
Conclusions: Combination of low doses of methylprednisolone and acetaminophen provide a safe and adequate 
clinical success on swelling.
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Introduction
After surgical removal of teeth, daily lives of patients 
are affected to different extents due to inflammatory 
response (1). Postoperative edema developing during 
this inflammatory process, even if short term, may raise 
esthetic concerns for the patient. Since the development 
of edema is important in the first 48 hours, this duration 
is important to prevent edema. After the development of 
edema, healing occurs in a one-week period. The short-
ening or elimination of this period gives the patient a 
great comfort.
The mechanism of the development of postoperative 
edema is the release of inflammatory mediators, like 
prostaglandins, leukotrienes, bradykinin and platelet 
activating factor to the wound region after surgical 
intervention, and vascular dilatation and permeability 
(2,3).Therefore, based on this, for decreasing vascular 
permeability that leads to acute inflammation and for 
reducing fluid transfer between tissues, various methods 
such as the use of non-steroid anti-inflammatory drugs 
(NSAIDs), various steroids, antihistaminic drugs, and 
enzymes, placement of drains, low level laser therapy, 
and ice therapy have been used (2,4-6).
Non-steroid anti-inflammatory drugs have been the 
most commonly used drug group in the postoperative 
period due to their practical use and wide availability. 
In the literature, there are numerous studies showing 
that these drugs, besides their analgesic properties, 
prevent or reduce postoperative edema. Dexketoprofen 
trometamol (DT) is a ketoprofen derived NSAID (7). 
The analgesic efficacy of DT, which is thought to affect 
inflammation by the inhibition of cyclooxygenase activ-
ity, has been widely studied in clinical trials, although 
sufficient emphasis has not been laid on its anti-inflam-
matory properties.
Acetaminophen, also called paracetamol, is a para-ami-
nophenol derivative non-opioid drug, with central an-
algesic and antipyretic effects (8). It is a weak inhibitor 
of cyclooxygenases in the peripheral tissues, and as it 
does not quite affect prostaglandin synthesis that has a 
great effect on the development of inflammation, some 
authors claim it has no anti-inflammatory effects, while 
some suggest that it has some anti-inflammatory prop-
erties (9-11). Corticosteroids are the most commonly 
preferred drugs among pharmaceutical agents by the 
clinicians for preventing and reducing edema. Corti-
costeroids show anti-inflammatory effects by inhibiting 
phospholipase A2 activation that provides the release 
of arachidonic acid into the inflammation region (phos-
pholipase A2 enzyme stimulates prostaglandins, leuko-
trienes, and neutrophil migration and causes inflamma-
tion) (12). Methylprednisolone is also a corticosteroid 
reducing macrophage infiltration in the inflammation 
region and the number and proliferation of fibroblasts 
in the connective tissue; additionally it suppresses the 
immune system (13). Among the mentioned edema 
prevention methods, there is no standard for doses of 
drugs. Based on the clinical studies ranging from us-
ing single drug dose to very high doses, and taking into 
account the side effects of the drugs, no optimal dose 
range could be determined. 
Therefore, this single blind study was planned to de-
termine the maximum clinical effect of methylpred-
nisolone, acetaminophen and DT on edema, keeping the 
repeat doses at minimum.
Material and Methods
Forty-five outpatients between 18 and 35 years of age, 
who attended Selcuk University Faculty of Dentistry the 
Department of Oral and Maxillofacial surgery, requir-
ing surgical removal of unilateral impacted mandibular 
third molar teeth under local anesthesia, were included 
in the study. The teeth were Class II, Class B according 
to Pell-Gregory and mesioangular according to Winter 
classifications. Bone removal and tooth sectioning were 
necessary in all operations. The study protocol and the 
informed consent forms were approved by the Research 
and Ethics Committee of the Yuzuncu Yil University, 
Faculty of Medicine (YYU-19062014/11). The study pro-
tocol was explained to the patients in detail after which 
consent was obtained. Patients with good oral hygiene, 
no contraindication to use corticosteroids, analgesics, 
or local anesthetics, without any systemic diseases and 
no drug intake within 24 hours of the operation were in-
cluded. All patients underwent clinical examination and 
panoramic radiographs were taken. All operations were 
performed by the same surgeon in an effort to minimize 
differences due to operator variability, using a stand-
ardized technique under local anesthesia. In all surgical 
interventions, mucoperiosteal flap and osteotomy were 
performed. For maintenance of anesthesia, 4% articaine 
HCl with 1:100.000 epinephrine was used.
Patients were randomly allocated into three groups. In 
the methylprednisolone group, each patient was given 
an intramuscular injection (gluteal region) of 40 mg 
methylprednisolone (Prednol-L, Mustafa Nevzat Drug 
Industry, Istanbul, Turkey) one hour before the opera-
tion and 20 mg methylprednisolone 24 hours after the 
removal of the impacted third molar. Patients in the 
methylprednisolone group were additionally given 300 
mg acetaminophen (Panalgine, Atabay Drug Industry, 
Istanbul Turkey) every 8 hours postoperatively. In the 
acetaminophen group, 300 mg acetaminophen (Panal-
gine, Atabay Drug Industry, Istanbul, Turkey) was given 
one hour before the surgery and 300 mg acetaminophen 
was continued postoperatively at every 8 hours for a 
minimum of two days. The DT group was administered 
12.5 mg DT (Arveles, Ufsa Drug Industry, Istanbul, 
Turkey) one hour before the operation and continued on 
12.5 mg DT every 8 hours postoperatively for two days. 
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All patients were given chlorhexidine mouthwash two 
times a day for seven days starting from the operation.
Each patient was evaluated preoperatively and 48 hours 
postoperatively by using ultrasound for facial swelling. 
The thickness of the soft tissue at the masseteric region 
was measured. For this step, patients were referred to 
the Radiology Department of Necmettin Erbakan Med-
ical Faculty. All examinations were performed by the 
same blinded radiologist and same ultrasound device 
(Logiq 9, GE, USA) with 7.5 MHz linear array trans-
ducer). Ultrasound examinations were performed in the 
supine position. For evaluation of facial swelling, ultra-
sound probe was placed parallel to the occlusal plane 
and perpendicular to mandibular ramus. Swelling was 
evaluated with preoperative and postoperative ultra-
sound images; the difference between the preoperative 
and postoperative measurements indicated the size of 
swelling.
Swelling 
Groups N Median 
 (Min-Max) 
Mean±SD p
Methylprednisolone+Acetaminophen 12 2.05 (0-5.8) 2.34±2.10 
0.077 Acetaminophen 12 3.0 (0-17.4) 3.73±4.81 
Dexketoprofen trometamol 12 4.20 (1.0-7.7) 4.58±2.33 
Total 36 3.25 (0-17.4) 3.55±3.35 
Table 1. Descriptive statistics for swelling in the groups and comparison results.
Min-Max: Minimum-Maximum; SD: Standard Deviation.
Statistical analysis of the study was performed us-
ing software program SPSS (version 21) for Windows. 
Kruskal-Wallis test was used. A p value <0.05 was con-
sidered statistically significant.
Results
The study was started with 45 patients; however, nine 
patients were eliminated because of failure to return for 
ultrasonographic evaluation. Of 36 patients, who suc-
cessfully completed the trial, 13 were men and 23 were 
women, with a mean age of 21.83 years. The mean op-
erative time from the initial incision to the final suture 
was recorded as 16.32 min.
Statistical analysis of the data indicated no differences 
between the groups with regard to swelling (Table 1). 
Although there was no significant difference between 
the groups, the effect of methylprednisolone plus aceta-
minophen was also evident on peak swelling, which was 
defined as the maximal swelling observed at the second 
day after surgery. According to the clinical results, peak 
swelling was markedly less in the methylprednisolone 
group than that in the acetaminophen and DT groups. 
Clinically, the highest swelling was observed in the DT 
group. No significant difference was found between 
the female and male patients in terms of postoperative 
swelling (Table 2). Moreover, no significant difference 
was determined among the groups in terms of age (Ta-
ble 2).
None of the patients experienced any adverse effects 
that could be attributed to drugs. However, two patients 
in the methylprednisolone group developed alveolar os-
teitis.
Discussion
Although there are studies evaluating the effect of dif-
ferent doses of various drugs on postoperative compli-
cations in the literature, we, in this study, examined the 
efficacy of different drug groups used in routine prac-
tice on postoperative edema with low repeated doses in 
order to keep the side effects at minimum.
Table 2. Age of the study groups and swelling according to gender and comparison results.
N Median (Min-Max) Mean±SD p
Age, years
 Methylprednisolone+Acetaminophen 12 20.00 (18.00-27.00) 21.33±2.84 
0.898  Acetaminophen 12 21.50 (18.00-27.00) 21.92±3.06 
 Dexketoprofen Trometamol 12 21.50 (18.00-35.00) 22.25±4.45 
Swelling 
 Female 23 3.20 (0.00-7.50) 3.08±2.40 
0.564  Male 13 3.30 (0.00-17.40) 4.37±4.59 
Min-Max: Minimum-Maximum; SD: Standard Deviation.
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This present study is important from the clinical stand-
point in terms of safe doses of commonly used drug 
groups in the postoperative period.
In the preference of the suitable corticosteroid accord-
ing to patient and procedure, it is quite important to 
prefer a drug with minimal mineralocorticoid activity 
and minimal effect on biological activity (14). As the 
duration of action and half-life (18 to 36 hours) of meth-
ylprednisolone is long and as it has almost no miner-
alocorticoid activity (14,15), we preferred to use meth-
ylprednisolone in this study. As known, although cor-
ticosteroid use may lead to various unwanted effects, 
short-term use in healthy individuals does not carry a 
risk for treatment delay and local infection (16). Cor-
ticosteroid use is among the etiological factors of post-
operative alveolar osteitis (17). Nevertheless, a study 
has shown that oral steroid use has no effect on alveolar 
osteitis (18). Considering that short-term low dose corti-
costeroid was used in the present study, it may be incor-
rect to attribute the development of alveolar osteitis in 
two patients in the methylprednisolone group to corti-
costeroid use. It was thought that these cases of alveolar 
osteitis might develop due to patient-related factor.
Studies on the removal of impacted tooth claim that pre-
operative single dose intramuscular use of 40 mg meth-
ylprednisolone is effective on inflammatory response 
(19,20). However, when half-life of methylprednisolone 
and the time that postoperative maximal swelling is 
observed are taken into account, a preoperative single 
dose may not be adequate.
In the literature, in a study that used a lower dose of 
methylprednisolone, 20 mg, by oral, IV, and IM route 
and evaluated the relation with anti-inflammatory ef-
fect, no statistically significant relationship was found; 
however, it was observed that intramuscular application 
is more successful clinically (21).
Although a standard dose could not be suggested based 
on the previous studies on prevention of postopera-
tive complications using methylprednisolone, the most 
frequently used dose is 40 mg (19,20,22,23). There are 
also studies in which methylprednisolone doses ranging 
from 15 mg up to 125 mg have been used (13,21,24-26). 
In the study by Vegas-Bustamente et al. (19), 40 mg of 
single dose methylprednisolone injected into the mas-
seter muscle after the extraction of impacted lower third 
molars was found to be effective on pain, trismus, and 
swelling. In their study, Micó-Llorens et al. (20) deter-
mined that single dose methylprednisolone injected via 
IM route just after surgical extraction of impacted low-
er third molars provided a comfortable postoperative 
course, particularly for the first postoperative 2 days, in 
terms of pain, trismus, and swelling. In our study, 40 mg 
intramuscular methylprednisolone was given as the first 
dose, a repeat dose of 20 mg methylprednisolone was 
also applied by the intramuscular route, and the patients 
in this group continued on 300 mg of acetaminophen as 
analgesic. Although our aim in the present study was to 
provide postoperative analgesic support rather than to 
increase the effects of the drugs, use of corticosteroid 
and acetaminophen together may have increased their 
potential effects. Despite there was no statistically sig-
nificant difference between the groups, the group that 
demonstrated the minimal postoperative swelling was 
the methylprednisolone plus acetaminophen group 
(49% more effective on swelling compared to DT and 
37% more effective on swelling compared to acetami-
nophen). We think that statistical success will reach 
clinical success, if the number of patients is increased.
Although acetaminophen has not been included in any 
anti-inflammatory drug group, it has been reported to 
demonstrate better anti-inflammatory effect at high 
doses, even better than NSAIDs. Bjørnsson et al. (10) 
compared the effects of 500 mg naproxen sodium, an 
analgesic NSAID, with 1000 mg acetaminophen in post-
operative inflammatory process and found that aceta-
minophen reduced the swelling by 22.4% in comparison 
to naproxen. In another study of the same authors, 1000 
mg acetaminophen was demonstrated to have preferable 
anti-inflammatory effects in comparison to 600 mg ibu-
profen (11). Nonetheless, there are studies reporting that 
acetaminophen used at high doses had no preventable 
effect on swelling (27). According to the results of our 
study, 300 mg acetaminophen exhibited approximate 
clinical results with 12.5 mg DT, a NSAID. However, 
generally speaking, acetaminophen used at these doses 
does not give well enough results on swelling.
Even though DT has been shown to be a good analgesic 
by numerous studies, the number of studies on its anti-
inflammatory properties is few. Although it has been 
reported that 25 mg DT has a greater anti-inflammatory 
effect than 600 mg ibuprofen on swelling after impact-
ed third molar surgery (28), it could not be mentioned 
about a sufficient anti-inflammatory effect with the 
half of the DT dose in the present study. Similar to this 
finding, Eroğlu et al. (29) reported that DT at a dose of 
12.5 mg was effective as analgesic but had a weak anti-
inflammatory effect on swelling and trismus in their 
study, in which the effects of 12.5 mg DT and 500 mg 
paracetamol on postoperative complications in bilateral 
symmetric impacted teeth were compared. Indeed, DT 
at a dose of  12.5 mg provides almost the same analgesic 
effect as dipyrone at a dose of 575 mg (30); however, it 
does not exhibit anti-inflammatory effect at this dose. 
As 12.5 mg is the safe dose of DT (DT has been re-
ported to have side effects at doses of 25 mg and over, 
especially in the presence of a systemic disease) (31,32), 
we preferred to use 12.5 mg DT in this study. Despite 
its side effects, DT is generally preferred to be used at a 
dose of 25 mg in the studies (28,33).
The majority of clinical studies are planned to determine 
Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e627-32.                                                                               Comparison of methylprednisolone, acetaminophen and dexketoprofen trometamol 
e631
the most efficacious and safest analgesic drug effective 
at the lowest dose possible. Analgesic efficacy of the 
drug groups we studied have been examined in numer-
ous studies and their analgesic efficacy were confirmed. 
However, there is limited number of studies investigat-
ing the anti-inflammatory effect of these drugs in the 
literature. Therefore, we evaluated the effects of the 
drug groups used in routine practice at the lowest doses 
possible on swelling which makes the patients feel un-
comfortable in the postoperative period. Conclusively, 
the drugs used in the present study at the given doses 
were well tolerated without any side effects. In patients 
undergoing oral surgery, the combination of preemp-
tive preoperative methylprednisolone and postoperative 
acetaminophen was found to be clinically successful on 
postoperative swelling without any side effects.
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